A Trial Examining the Treatment of Common Warts With Combination Liquid Nitrogen (LN2) and Cantharidin

Completed · Not applicable · Has a placebo group

Conditions studied: Verruca Vulgaris

In brief

The purpose of the study was to see if liquid nitrogen, a commonly used treatment for warts, is more effective if it is used alone, or if it is more effective if combined with cantharidin, a topical treatment also commonly used for warts (verruca vulgaris).

Key facts

Study ID

NCT01084824

Run by

North Idaho Dermatology

People needed

70

Starts

2007-06-01

Expected to finish

2008-09-01

Last updated by the study team

2010-03-11

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• common warts on non-genital, non-facial skin
• otherwise healthy
• between 18-65 and able to give informed consent
• capable of tolerating treatment

You may not qualify if…

• Ill-health
• Poor tolerance or sensitivity to treatments in study
• <18 years old; >65 years old
• verruca plana or condyloma acuminata
• immunosuppression or immune dysfunction
• significant peripheral vascular disease
• significant sensitivity to cold
• epidermodysplasia verruciformis
• mosaiform warts or periungual warts

Where it is running

• North Idaho Dermatology — Coeur d'Alene, Idaho, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.